248 related articles for article (PubMed ID: 17699239)
1. Mechanisms and role of HLA and non-HLA alloantibodies.
Tinckam KJ; Chandraker A
Clin J Am Soc Nephrol; 2006 May; 1(3):404-14. PubMed ID: 17699239
[TBL] [Abstract][Full Text] [Related]
2. Antibody-mediated rejection: treatment alternatives and outcomes.
Singh N; Pirsch J; Samaniego M
Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
[TBL] [Abstract][Full Text] [Related]
3. Antibody-mediated rejection.
Akalin E; Watschinger B
Semin Nephrol; 2007 Jul; 27(4):393-407. PubMed ID: 17616272
[TBL] [Abstract][Full Text] [Related]
4. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation.
Dragun D
Transplantation; 2008 Oct; 86(8):1019-25. PubMed ID: 18946337
[TBL] [Abstract][Full Text] [Related]
5. The role of HLA-specific antibodies in kidney transplant rejection: published studies and local data.
Worthington JE; Martin S; Barker AJ; McWilliam LJ; Dyer PA
Clin Transpl; 2006; ():349-61. PubMed ID: 18365389
[TBL] [Abstract][Full Text] [Related]
6. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
7. De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact.
Seveso M; Bosio E; Ancona E; Cozzi E
Contrib Nephrol; 2009; 162():87-98. PubMed ID: 19001816
[TBL] [Abstract][Full Text] [Related]
8. Progress in understanding humoral rejection in kidney transplantation: implications for patient management.
Pascual MA; Crespo M; Tolkoff-Rubin N
Nefrologia; 2001; 21(4):327-31. PubMed ID: 11816504
[TBL] [Abstract][Full Text] [Related]
9. B cells: a rational target in alloantibody-mediated solid organ transplantation rejection.
Pescovitz MD
Clin Transplant; 2006; 20(1):48-54. PubMed ID: 16556153
[TBL] [Abstract][Full Text] [Related]
10. De novo production of donor-specific anti-HLA alloantibodies in early acute humoral renal allograft rejection.
Spriewald BM; Hugo C
Clin Transpl; 2006; ():469-72. PubMed ID: 18365405
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of anti-HLA antibodies via proteasome inhibition.
Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
[TBL] [Abstract][Full Text] [Related]
12. [Anti-HLA antibody detection and rejection in kidney transplantation: impact of the new technologies].
Georgescu D; Ferrari-Lacraz S; Villard J
Rev Med Suisse; 2007 Apr; 3(108):1064-9. PubMed ID: 17552259
[TBL] [Abstract][Full Text] [Related]
13. Detailed examination of HLA antibody development on renal allograft failure and function.
Zhu L; Lee PC; Everly MJ; Terasaki PI
Clin Transpl; 2008; ():171-87. PubMed ID: 19711514
[TBL] [Abstract][Full Text] [Related]
14. Sensitization after kidney transplantation.
Akalin E; Pascual M
Clin J Am Soc Nephrol; 2006 May; 1(3):433-40. PubMed ID: 17699242
[TBL] [Abstract][Full Text] [Related]
15. Determinants of the complement-fixing ability of recipient presensitization against HLA antigens.
Bartel G; Wahrmann M; Exner M; Regele H; Schillinger M; Hörl WH; Böhmig GA
Transplantation; 2007 Mar; 83(6):727-33. PubMed ID: 17414705
[TBL] [Abstract][Full Text] [Related]
16. Reviews on mysterious vascular endothelial cells in renal allografts.
Yamaguchi Y
Clin Transplant; 2012 Jul; 26 Suppl 24():13-9. PubMed ID: 22747470
[TBL] [Abstract][Full Text] [Related]
17. Pre-formed donor-specific alloantibodies (DSA) detected only by luminex technology using HLA-coated microspheres and causing acute humoral rejection and kidney graft dysfunction.
Muro M; Llorente S; Gónzalez-Soriano MJ; Minguela A; Gimeno L; Alvarez-López MR
Clin Transpl; 2006; ():379-83. PubMed ID: 18365392
[TBL] [Abstract][Full Text] [Related]
18. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
19. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
20. Relevance of MICA and other non-HLA antibodies in clinical transplantation.
Sumitran-Holgersson S
Curr Opin Immunol; 2008 Oct; 20(5):607-13. PubMed ID: 18675346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
